When GLP-1 receptor agonists are used with insulin or sulfonylureas, the risk of hypoglycaemia increases, and dose reductions of these medications may be necessary
Its growing cardiovascular-outcomes evidence, combined with expanding reimbursement and manufacturing capacity, positions it to capture an estimated 44% share of global obesity GLP-1 sales by 2035
By combining advanced medication with behavior change, this program is designed to boost weight loss compared to GLP-1s alone
BGM is needed before meals to give the user the chance to adjust the meal insulin dose if the pre-meal glucose is out of range at the time, while measurements over a few days will show whether the doses active before that meal require adjustment
Its not just filled with fiber, but also gives you a dose of plant-based protein
95% CI, 0.08 to 4.21) [79]